CIK 0001116463
- Accelerated filer
ORASURE TECHNOLOGIES INC
Sign in to watch- Ticker
- OSUR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364370966
- Phone
- +1 503-641-6115
- Business address
- 220 E FIRST ST, BETHLEHEM, PA, 18015
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-18 | LANCASTER RONNY B Director | Grant or award | +6,577 | $15.97 | $105K | 23,830 |
| 2020-05-15 | HOBBS EAMONN P Director | Shares withheld for taxes | −2,724 | $16.04 | $44K | 27,778 |
| 2020-05-15 | Aspinall Mara G. Director | Shares withheld for taxes | −3,343 | $16.04 | $54K | 20,183 |
| 2020-05-15 | Patrick Charles W Director | Shares withheld for taxes | −3,990 | $16.04 | $64K | 58,446 |
| 2020-05-15 | Celano Michael Director | Shares withheld for taxes | −3,843 | $16.04 | $62K | 58,799 |
| 2020-05-15 | LANCASTER RONNY B Director | Shares withheld for taxes | −3,776 | $16.04 | $61K | 17,253 |
| 2020-05-11 | Nibauer Lisa EVP & BU Lead - Infectious | Grant or award | +14,071 | $17.77 | $250K | 14,071 |
| 2020-05-07 | Cuca Roberto CFO | Shares withheld for taxes | −1,359 | $16.10 | $22K | 91,353 |
| 2020-04-08 | Datin James A Director | Grant or award | +2,145 | $10.61 | $23K | 15,577 |
| 2020-04-08 | Datin James A Director | Shares withheld for taxes | −586 | $10.61 | $6K | 14,991 |
| 2020-04-06 | Shulkin David Director | Grant or award | +8,965 | $11.16 | $100K | 8,965 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −1,536 | $7.17 | $11K | 61,843 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −901 | $7.17 | $6K | 60,942 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −1,467 | $7.17 | $11K | 59,475 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Grant or award | +32,516 | $7.17 | $233K | 91,991 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Grant or award | +10,238 | $7.17 | $73K | 102,229 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −3,023 | $7.17 | $22K | 99,206 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Grant or award | +10,238 | $7.17 | $73K | 109,444 |
| 2020-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −2,900 | $7.17 | $21K | 106,544 |
| 2020-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Shares withheld for taxes | −3,736 | $7.17 | $27K | 179,874 |
Page 15 of 35 · 697 trades